Product Pathways - Lymphocyte Signaling
CIITA Antibody #3793
|3793S||100 µl (10 western blots)||---||In Stock||---|
|3793||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Specificity / Sensitivity
CIITA Antibody detects transfected levels of total CIITA protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Glu149 of human CIITA. Antibodies are purified by peptide affinity chromatography.
MHC class II (MHC-II) proteins play critical roles in cellular immune responses and their expression is mainly regulated by the non-DNA binding transcription factor CIITA (MHC class II transactivator) (1,2). CIITA expression is upregulated by IFN-γ and it in turn enchances MHC-II expression and represses collagen expression (3,4). CIITA has a limited number of transcriptional targets, most of which are involved in MHC-mediated antigen presentation (5). Mutations in the CIITA are associated with the hereditary immunodeficiency disease Bare Lymphocyte Syndrome (BLS) which is characterized by a nearly complete absence of MHC-II expression (also referred to as MHC-II deficiency) (6,7).
- Ting, J.P. and Trowsdale, J. (2002) Cell 109 Suppl, S21-33.
- Drozina, G. et al. (2005) Curr Top Microbiol Immunol 290, 147-70.
- Dong, Y. et al. (1999) J Immunol 162, 4731-9.
- Butticè, G. et al. (2006) Circ Res 98, 472-9.
- Krawczyk, M. et al. (2008) PLoS Genet 4, e1000058.
- Reith, W. and Mach, B. (2001) Annu Rev Immunol 19, 331-73.
- Waldburger, J.M. et al. (2000) Immunol Rev 178, 148-65.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.